SEC Info - Thermo Fisher Scientific Inc.

SEC Info℠

Home

Help

Please Sign In

Thermo Fisher Scientific Inc. – ‘8-K’ for 1/31/24

On: Wednesday, 1/31/24, at 6:02am ET · For: 1/31/24 · Accession #: 97745-24-3 · File #: 1-08002

  As Of               Filer                 Filing    For·On·As Docs:Size

 1/31/24  Thermo Fisher Scientific Inc.     8-K:2,9     1/31/24   12:754K

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     47K 
 2: EX-99.1     Press Release and Earnings Tables                   HTML    421K 
 7: R1          Document and Entity Information                     HTML     87K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
12: XML         XBRL Instance -- tmo-20240131_htm                    XML     52K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      9K 
 4: EX-101.DEF  XBRL Definitions -- tmo-20240131_def                 XML     56K 
 5: EX-101.LAB  XBRL Labels -- tmo-20240131_lab                      XML    134K 
 6: EX-101.PRE  XBRL Presentations -- tmo-20240131_pre               XML     58K 
 3: EX-101.SCH  XBRL Schema -- tmo-20240131                          XSD     21K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               19±    27K 
11: ZIP         XBRL Zipped Folder -- 0000097745-24-000003-xbrl      Zip     53K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX:

tmo-20240131

i 0000097745 i FALSE00000977452024-01-312024-01-310000097745us-gaap:CommonStockMember2024-01-312024-01-310000097745tmo:SeniorNotes0.75Due2024Member2024-01-312024-01-310000097745tmo:SeniorNotes0.125Due2025Member2024-01-312024-01-310000097745tmo:SeniorNotes200Due2025Member2024-01-312024-01-310000097745tmo:SeniorNotes3200Due2026Member2024-01-312024-01-310000097745tmo:SeniorNotes1.40Due2026Member2024-01-312024-01-310000097745tmo:A1.45SeniorNotesDue2027Member2024-01-312024-01-310000097745tmo:SeniorNotes175Due2027Member2024-01-312024-01-310000097745tmo:SeniorNotes0.500Due2028Member2024-01-312024-01-310000097745tmo:SeniorNotes1.375Due2028Member2024-01-312024-01-310000097745tmo:SeniorNotes1.95Due2029Member2024-01-312024-01-310000097745tmo:SeniorNotes0.875Due2031Member2024-01-312024-01-310000097745tmo:SeniorNotes2375Due2032Member2024-01-312024-01-310000097745tmo:SeniorNotes3650Due2034Member2024-01-312024-01-310000097745tmo:SeniorNotes2.875Due2037Member2024-01-312024-01-310000097745tmo:SeniorNotes1.500Due2039Member2024-01-312024-01-310000097745tmo:SeniorNotes1.875Due2049Member2024-01-312024-01-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i January 31, 2024

i THERMO FISHER SCIENTIFIC INC.

(Exact name of Registrant as specified in its Charter)

i Delaware

i 1-8002

i 04-2209186

(State of incorporation)

(Commission File Number)

(I.R.S. Employer Identification Number)

i 168 Third Avenue

i Waltham, i Massachusetts i 02451

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: ( i 781) i 622-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

i Common Stock, $1.00 par value

i TMO

i New York Stock Exchange

i 0.750% Notes due 2024

i TMO 24A

i New York Stock Exchange

i 0.125% Notes due 2025

i TMO 25B

i New York Stock Exchange

i 2.000% Notes due 2025

i TMO 25

i New York Stock Exchange

i 3.200% Notes due 2026

i TMO 26B

i New York Stock Exchange

i 1.400% Notes due 2026

i TMO 26A

i New York Stock Exchange

i 1.450% Notes due 2027

i TMO 27

i New York Stock Exchange

i 1.750% Notes due 2027

i TMO 27B

i New York Stock Exchange

i 0.500% Notes due 2028

i TMO 28A

i New York Stock Exchange

i 1.375% Notes due 2028

i TMO 28

i New York Stock Exchange

i 1.950% Notes due 2029

i TMO 29

i New York Stock Exchange

i 0.875% Notes due 2031

i TMO 31

i New York Stock Exchange

i 2.375% Notes due 2032

i TMO 32

i New York Stock Exchange

i 3.650% Notes due 2034

i TMO 34

i New York Stock Exchange

i 2.875% Notes due 2037

i TMO 37

i New York Stock Exchange

i 1.500% Notes due 2039

i TMO 39

i New York Stock Exchange

i 1.875% Notes due 2049

i TMO 49

i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

On January 31, 2024, the Registrant announced its financial results for the fiscal quarter and year ended December 31, 2023. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.

The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release dated January 31, 2024

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


		THERMO FISHER SCIENTIFIC INC.


Date:	January 31, 2024	By:	/s/ *Joseph R. Holmes*
			Joseph R. Holmes
			Vice President and Chief Accounting Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	1/31/24
	12/31/23	4
		List all Filings

↑Top

Filing Submission 0000097745-24-000003 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Thermo Fisher Scientific Inc. – ‘8-K’ for 1/31/24

On: Wednesday, 1/31/24, at 6:02am ET · For: 1/31/24 · Accession #: 97745-24-3 · File #: 1-08002

Previous ‘8-K’: ‘8-K’ on / for 12/5/23 · Next & Latest: ‘8-K’ on / for 4/24/24

Current Report — Form 8-KFiling Table of Contents

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Current Report — Form 8-K

Filing Table of Contents